Bristol-Myers Squibb To Pay $19.5M Over Abilify Marketing
Bristol-Myers Squibb will pay $19.5 million to 42 states and Washington, D.C., to settle claims that the company allegedly improperly marketed the antipsychotic drug Abilify, multiple states' attorneys general announced Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article